|
(R)-acetoin
|
DB04364 |
[A product of fermentation. It is a component of the butanediol cycle in microorganisms. In mammals it is oxidized to carbon dioxide.] |
|
Methyldiazene
|
DB04361 |
|
|
4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole
|
DB03030 |
|
|
Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide
|
DB03031 |
|
|
Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid
|
DB04362 |
|
|
Benzo[B]Thiophene-2-Boronic Acid
|
DB04360 |
|
|
Agatolimod
|
DB15018 |
[Agatolimod is under investigation in clinical trial NCT00471471 (Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery).] |
|
Enoblituzumab
|
DB15017 |
[Enoblituzumab is under investigation in clinical trial NCT02982941 (Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors).] |
|
Mongersen
|
DB15019 |
[Mongersen is under investigation in clinical trial NCT02957474 (A Study to Evaluate the Effect of Food, Formulation Strength, and a Proton Pump Inhibitor on GED 0301 Pharmacokinetics in Healthy Adult Subjects).] |
|
Gremubamab
|
DB15014 |
[Gremubamab is under investigation in clinical trial NCT02255760 (Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults).] |
|
TAK-243
|
DB15013 |
[TAK-243 is under investigation in clinical trial NCT03816319 (TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Refractory Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia).] |
|
Palladium Pd-103
|
DB15016 |
[Palladium Pd-103 is under investigation in clinical trial NCT00247312 (Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial).] |
|
Recombinant CD40-ligand
|
DB15015 |
[Recombinant CD40-ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma).] |
|
Edasalonexent
|
DB15010 |
[Edasalonexent is under investigation in clinical trial NCT01511900 (A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes).] |
|
Farampator
|
DB15012 |
[Farampator is under investigation in clinical trial NCT00113022 (Org 24448 to Treat Major Depression).] |
|
Avacopan
|
DB15011 |
[Avacopan is under investigation in clinical trial NCT02994927 (A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis).] |
|
1,3,2-Dioxaborolan-2-Ol
|
DB04369 |
|
|
LY341770
|
DB03038 |
|
|
4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide
|
DB03039 |
|
|
Debromohymenialdisine
|
DB04367 |
|
